TrialStem cell research & therapy2025

Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson's disease clinical trial.

Juan D Martinez-Lemus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.